1. Stéphan JL, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, et al. (2001) Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 40(:1285-92.
2. Wakiguchi H, Hasegawa S, Hirano R, Kaneyasu H, Wakabayashi-Takahara M, et al. (2015) Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels. Pediat Rheumatolog J 13: 49.
3. Lilleby V, Haydon J, Sanner H, Krossness BK, Ringstad G, et al. (2014) Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis. Scandinavian J rheumatolog 43: 171-3.
4. Yamashita H, Matsuki Y, Shimizu A, Mochizuki M, Takahashi Y, et al. (2013) Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review. Modern rheumatology 23: 386-92.
5. Bustos BR, Carrasco AC, Toledo RC (2012) Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis. Anales de Pediatria 77: 47-50.
Kobayashi I, Kawamura N, Okano M, Sageshima S, Nakayama T, et al. (2006) Thrombocytopaenia in juvenile drmatomyositis. Scandinavian journal of rheumatology 35: 79–80.
6. Sterba G, Rodriguez C, Sifontes S, Vigilanza P (2004) Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis. J rheumatology 31: 1014-5.
7. Kobayashi I, Yamada M, Kawamura N, Kobayashi R, Okano M, et al. (2000) Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis. Acta Paediatrica 89: 617–19.
8. Yajima N, Wakabayashi K, Odai T, Isozaki T, Matsunawa M, et al. (2008) Clinical Features of Hemophagocytic Syndrome in Patients with Deramtomyositis. The journal of rheumatology 35: 1838-1841.
9. Yamashita H, Matsuki Y, Shimizu A, Mochizuki M, Takahashi Y, et al. (2013) Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review. Modern rheumatology 23: 386–92.
10. Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia G (2014) A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: A challenging clinical case in light of the current diagnostic criteria. Autoimmunity rev 13: 1142-8.
11. Onen S, Umit Z, Siviş Z, Evin F, Kasap M, et al. (2014) Juvenile dermatomyositis with a rare and severe complication: macrophage activation syndrome. J Pediatric Res 1: 218-21.
12. Barreiro-González A, Cerdà-Ibáñez M, Barranco Gonzalez H, Harto Castano MA, Calvo Penades I, et al. (2018) Retinopatía Purtscher-like asociada a dermatomiositis y linfohistiocitosis hemofagocítica. Arch Soc Esp Oftalmol 93: 202-5.
13. Deschamps R, Couture J, Hadjinicolaou A, LeBlanc C (2018) A 17-year-old girl with facial edema and weakness. Paediatrics & Child Health 23: 241–4.
14. Poddighe D, Dauyey K (2020) Macrophage activation syndrome in juvenile dermatomyositis: a systematic review. Rheumatology Int 40: 695–702.
15. Mamyrova G, Kishi T, Targoff I (2018) Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford) 57: 1956-63.
16. Tansley S, Betteridge Z, Gunawardena H (2014) Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Research & Therapy 16: R138.
17. Volochayev R, Csako G, Wesley R (2012) Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups. Open Rheumatol J 6: 54-63.
18. Minoia F, Davi S, Horne A, Demirkaya E, Bovis F, Li C, et al. (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis rheumatology 66: 3160-9.
19. Borgia RE, Gerstein M, Levy DM, Silverman ED, Hiraki LT (2018) Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis and rheumatolog 70: 616–24.
20. Wang W, Gong F, Zhu W, Fu S, Zhang Q (2015) Macrophage activation syndrome in Kawasaki disease: more common than we thought? Seminars in arthritis and rheumatism 44: 405-10.
21. Li J, Wang Q, Zheng W, Ma J, Zhang W, (2014) Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 93: 100-5.
22. Schulert GS, Grom AA (2014) Macrophage activation syndrome and cytokine-directed therapies. Best Practice & Research Clinical Rheumatolog 28: 277-92.
23. Shimizu M, Yokoyama T, Tokuhisa Y, Ishikawa S, Sakakibara Y, et al. (2013) Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clinical Immunolog 146: 736.
24. Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, (2012) Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clinical Rheumatolog 31: 1223-30.
25. Brisse E, Wouters CH, Andrei G, Matthys P (2017) How viruses contribute to the pathogenesis of hemophagocytic lymphohistiocytosis. Frontiers in immunol 8: 1102.
26. Cusini HF, Gunthard G, Stussi (2010) Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first case. Infection 38: 423-6.
27. S Frimmel, J Schipper, J Henschel (2014) First description of single-pass albumin dialysis combined with cytokine adsorption in fulminant liver failure and hemophagocytic syndrome resulting from generalized herpes simplex virus 1 infection. Liver Transpl 20: 1523–4.
28. Drori A, Ribak Y, P Vernon van Heerden, et al. (2015) Hemophagocytic lymphohistiocytosis due to acute primary herpes simplex virus 1 infection. J Clin Virol 2015 68: 6-10.
29. Yabushita T, Yoshioka S, Koba Y (2017) Successful Treatment of Herpes Simplex Virus (HSV)-1-associated Hemophagocytic Lymphohistiocytosis (HLH) with Acyclovir: A Case Report and Literature Review. Internal Medicine 56: 2919-2923.
30. Schwartz M, O'Brien C, Raya N (2019) Acquired Hemophagocytic Lymphohistiocytosis Associated With Disseminated Herpes Simplex Virus in Immunocompetent Host. ACG Case Rep J 6: e00164.
31. Shah M, Targoff IN, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotype in juvenilemyositis. Arthritis and rheumatism 65: 1934-41.
32. Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Muller I, et al. (2015) Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. British J haematol 170: 539-49.
33. Ravelli A, Minoia F, Davi S (2016) Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis and rheumatol 68: 566-76.
34. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). New England J med 292: 344-7.
35. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). England J med 292: 403-7.
36. Abdul-Aziz R, Yu C, Adler B (2017) Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM). Pediatr Rheumatol Online J 15: 25.
37. Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, et al. (2012) Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clinical rheumatolog 31: 1223-30.
38. Russo RA, Katsicas MM, Dávila M, Ciocca M, Zelazko M (2001) Cholestasis in juvenile dermatomyositis: report of three cases. Arthritis and rheumatology 44: 1139-42.
39. Lerkvaleekul B, Vilaiyuk S (2018) Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol 10: 117-28.
40. Tristano AG, Casanova-Escalona L, Torres A, Rodriguez MA (2003) Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy. Journal of clinical rheumatolog 9: 253–8.
41. Sawhney S, Woo P, Murray KJ (2001) Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Archives of Disease in Childhood 85: 421-6.